Apolipoprotein B and Lipid Profile among Patients Diagnosed with Acute Myocardial Infarction
Apolipoprotein B and Lipid Profile
DOI:
https://doi.org/10.54393/pbmj.v5i7.644Keywords:
Lipid profile, Atherosclerosis cardiovascular disease, Total cholesterol, Apolipoprotein B, Acute myocardial infractionAbstract
Highest mortality rates are associated with acute myocardial infraction. It is recognized as leading cause of deaths globally. It is sequelae to the atherosclerosis cardiovascular disease (ASCVD). There is a close relationship between the Apo lipoprotein B abundance and atherosclerosis. Objectives: To estimate the ApoB blood levels and its usefulness and to analyze the total cholesterol TC, non-HDL cholesterol, triglycerides, high density lipoprotein cholesterol (HDL-C), LDL/HDL and low density lipoprotein cholesterol (LDL-C) ratios in AMI patients. Methods: It was a comparative cross-sectional study with statistical approach, conducted at Akbar Niazi Teaching Hospital, Islamabad and Khyber Teaching Hospital, Peshawar. The study was conducted on the 53 males and 28 female attended the cardiovascular center of the hospital. The duration of the study was from December 2021 to May 2022. The convenient sampling technique was used for the sampling of the enrolled patients. The healthy patients were included in the control group. The tubidimetric method was laboratory analysis and for lipid profiling the Apolipoprotein B and enzymatic method was used. The SPSS version 21.0 was used for the statistical analysis. Results: The ratio of males to females was 1.8:1. The Myocardial infarction range of the patients was selected from more than 31 years to 84 years. The 55 10 was the average age of the patients included in the study. However, 61 years of age was the median and the interquartile limit was 46 to 61 years for male patients, and for female patients was 49 to 68 years. Of 93 patients (6.5 %) the sufferers were of age lower than 40 years, 46 patients were smokers in the experimental group and in the control group, only 15 people were smokers. The 99 ± 17.8 was the mean level and SD of the experimental group. The moderate correlation was observed in the ApoB, non-HDL cholesterol and HDL-cholesterol. Conclusions: The moderate correlation between Apo B and non HDL-C and HDL-C were observed in the AMI patients. It was a complementary marker in the conventional lipid profiling
References
Goswami B, Rajappa M, Mallika V, Kumar S, Shukla DK. Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction. Acta Cardiologica. 2008 Dec; 63(6):749-55. doi: 10.2143/AC.63.6.2033393
Semb AG, Kvien TK, Aastveit AH, Jungner I, Pedersen TR, Walldius G, et al. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality Risk (AMORIS) Study. Annals of the Rheumatic Diseases. 2010 Nov; 69(11):1996-2001. doi: 10.1136/ard.2009.126128.
Erem C, Kocak M, Nuhoglu I, Yılmaz M, Ucuncu O. Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma. Clinical Endocrinology. 2010 Oct;73(4):502-7. doi: 10.1111/j.1365-2265.2009.03752.x
Galal H, Samir A, Shehata M. Assessment of apolipoprotein B/apolipoprotein A-I ratio in non-ST segment elevation acute coronary syndrome patients. The Egyptian Heart Journal. 2020 May; 72(1):27. doi: 10.1186/s43044-020-00057-1
De Padua Mansur A, Annicchino-Bizzacchi J, Favarato D, Avakian SD, Machado César LA, Franchini Ramires JA. Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease. The American Journal of Cardiology. 2000 May; 85(9):1089-93. doi: 10.1016/s0002-9149(00)00701-3
Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Human Genetics. 1984; 65(3):237-41. doi: 10.1007/BF00286509
Goswami B, Rajappa M, Chakraborty B, Patra SK, Kumar S, Mallika V. Comparison of the various lipid ratios and indices for risk assessment in patients of myocardial infarction. Clinical Biochemistry. 2012 Apr; 45(6):445-9. doi: 10.1016/j.clinbiochem.2012.01.019
Sypniewska G, Bergmann K, Krintus M, Koziński M, Kubica J. How do apolipoproteins ApoB and ApoA-I perform in patients with acute coronary syndromes. Journal of Med Biochemistry. 2011; 30 (3): 237-43. DOI: 10.2478/v10011-011-0022-6
Bartnik M, Malmberg K, Hamsten A, Efendic S, Norhammar A, Silveira A, et al. Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls. Journal of Internal Medicine. 2004 Oct; 256(4):288-97. doi: 10.1111/j.1365-2796.2004.01371.x
Yang N, Feng JP, Chen G, Kou L, Li Y, Ren P, et al. Variability in lipid profile among patients presented with acute myocardial infarction, unstable angina and stable angina pectoris. European Review for Medical and Pharmacological Sciences. 2014; 18(24):3761-6
Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X, et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. Journal of the American College of Cardiology. 2009 Jan; 53(3):244-53. doi: 10.1016/j.jacc.2008.09.041
Cui Y, Li S, Zhang F, Song J, Lee C, Wu M, et al. Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction. Clinical Cardiology. 2019 Mar;42(3):385-390. doi: 10.1002/clc.23154
Wattanasuwan N, Khan IA, Gowda RM, Vasavada BC, Sacchi TJ. Effect of acute myocardial infarction on cholesterol ratios. Chest. 2001 Oct; 120(4):1196-9. doi: 10.1378/chest.120.4.1196
Karahan Z, Uğurlu M, Uçaman B, Uluğ AV, Kaya İ, Çevik K, et al. Relation between Apolipoprotein E Gene Polymorphism and Severity of Coronary Artery Disease in Acute Myocardial Infarction. Cardiology Research and Practice. 2015; 2015:363458. doi: 10.1155/2015/363458
Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestley LM, et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet. 1986 Jun; 1(8493):1301-3. doi: 10.1016/s0140-6736(86)91222-5
Yaseen RI, El-Leboudy MH, El-Deeb HM. The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome. The Egyptian Heart Journal. 2021 Mar; 73(1):24. doi: 10.1186/s43044-021-00150-z
Miremadi S, Sniderman A, Frohlich J. Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders? Clinical Chemistry. 2002 Mar; 48(3):484-8
Rasmussen HS, Aurup P, Goldstein K, McNair P, Mortensen PB, Larsen OG, et al. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study. Archives of Internal Medicine. 1989 May; 149(5):1050-3.
González-Pacheco H, Vargas-Barrón J, Vallejo M, Piña-Reyna Y, Altamirano-Castillo A, Sánchez-Tapia P, et al. Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease. Therapeutics and Clinical Risk Management. 2014 Oct; 10:815-23. doi: 10.2147/TCRM.S67945
Krintus M, Kozinski M, Stefanska A, Sawicki M, Obonska K, Fabiszak T, et al. Value of C-reactive protein as a risk factor for acute coronary syndrome: a comparison with apolipoprotein concentrations and lipid profile. Mediators of Inflammation. 2012; 2012:419804. doi: 10.1155/2012/419804
Genest JJ Jr, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD, et al. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis. 1990 May; 82(1-2):7-17. doi: 10.1016/0021-9150(90)90138-9.
Myant NB, Gallagher JJ, Knight BL, McCarthy SN, Frostegård J, Nilsson J, et al. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 1991 Jun; 11(3):691-703. doi: 10.1161/01.atv.11.3.691
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@pakistanbmj.com
